ResearchSafe

PTD-DBM (PTD-DBM (Wnt Pathway Hair Peptide))

Category: Hair Growth. Status: Research peptide (topical).

A cell-penetrating peptide researched for hair regeneration by activating the Wnt/beta-catenin pathway. It became popular in biohacker hair protocols after studies paired it with valproic acid to induce new follicle formation.

How it works

PTD-DBM disrupts the interaction between CXXC5 and Dishevelled, releasing a natural brake on the Wnt/beta-catenin signaling pathway. Enhanced Wnt signaling promotes hair follicle neogenesis and regeneration.

Key facts

  • Molecular weight: ~ (short cell-penetrating peptide)
  • Half-life: Topical (local action)
  • Bioavailability: Topical (local delivery)
  • Storage: Refrigerate reconstituted solution; keep lyophilized cool and dry.

Dosing overview

  • Typical dose: Topical scalp application (research)
  • Frequency: Daily
  • Duration: Ongoing (research)
  • Route: Topical

Protocol notes

  • Applied topically to the scalp, often reconstituted in a suitable carrier solution.
  • Frequently paired with valproic acid, which also activates Wnt signaling, in research protocols.
  • Consistent daily use over months is used to assess follicle regeneration.

Reported benefits

  • Activates Wnt/beta-catenin hair pathway
  • Promotes follicle neogenesis (research)
  • Synergy with valproic acid
  • Non-hormonal hair mechanism

Possible side effects

  • Scalp irritation (possible)
  • Unknown long-term human safety
  • No approved human products

Research

  • PTD-DBM induces hair follicle neogenesis (2017): Topical PTD-DBM with valproic acid activated Wnt/beta-catenin signaling and induced new hair follicle formation in animal models.

Compare PTD-DBM

Research and educational reference only. Not medical advice.